Learn more Got it! About Us Our BioBank Platform Technology Our Drug Programmes News Contact us INVESTORS NEWS LATEST NEWS 11th November 2021 Synairgen completes Phase III recruitment READ MORE ABOUT OUR TRIALS ABOUT US COVID-19 PEER-REVIEWED DATA COPD BIOBANK PLATFORM Managed Access Program For more information on the Managed Access Program please click here. Synairgen plc Registered in England and Wales No. 5233429 Registered office Mailpoint 810, Level F, South Block, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK